Global Efavirenz Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
LPI (LP Information)' newest research report, the “Efavirenz Industry Forecast” looks at past sales and reviews total world Efavirenz sales in 2022, providing a comprehensive analysis by region and market sector of projected Efavirenz sales for 2023 through 2029. With Efavirenz sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Efavirenz industry.
This Insight Report provides a comprehensive analysis of the global Efavirenz landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Efavirenz portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Efavirenz market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Efavirenz and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Efavirenz.
The global Efavirenz market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Efavirenz is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Efavirenz is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Efavirenz is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Efavirenz players cover Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero, Strides Pharma and Gilead Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Efavirenz market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Efavirenz market?
What factors are driving Efavirenz market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Efavirenz market opportunities vary by end market size?
How does Efavirenz break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
LPI (LP Information)' newest research report, the “Efavirenz Industry Forecast” looks at past sales and reviews total world Efavirenz sales in 2022, providing a comprehensive analysis by region and market sector of projected Efavirenz sales for 2023 through 2029. With Efavirenz sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Efavirenz industry.
This Insight Report provides a comprehensive analysis of the global Efavirenz landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Efavirenz portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Efavirenz market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Efavirenz and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Efavirenz.
The global Efavirenz market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Efavirenz is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Efavirenz is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Efavirenz is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Efavirenz players cover Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero, Strides Pharma and Gilead Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Efavirenz market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Single Efavirenz
- Two-drug combination
- Three-drug combination
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Teva
- Mylan
- Aurobindo Pharma
- Cipla
- Macleods Pharmaceuticals
- Hetero
- Strides Pharma
- Gilead Sciences
What is the 10-year outlook for the global Efavirenz market?
What factors are driving Efavirenz market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Efavirenz market opportunities vary by end market size?
How does Efavirenz break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Efavirenz Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Efavirenz by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Efavirenz by Country/Region, 2018, 2022 & 2029
2.2 Efavirenz Segment by Type
2.2.1 Single Efavirenz
2.2.2 Two-drug combination
2.2.3 Three-drug combination
2.3 Efavirenz Sales by Type
2.3.1 Global Efavirenz Sales Market Share by Type (2018-2023)
2.3.2 Global Efavirenz Revenue and Market Share by Type (2018-2023)
2.3.3 Global Efavirenz Sale Price by Type (2018-2023)
2.4 Efavirenz Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Efavirenz Sales by Application
2.5.1 Global Efavirenz Sale Market Share by Application (2018-2023)
2.5.2 Global Efavirenz Revenue and Market Share by Application (2018-2023)
2.5.3 Global Efavirenz Sale Price by Application (2018-2023)
3 GLOBAL EFAVIRENZ BY COMPANY
3.1 Global Efavirenz Breakdown Data by Company
3.1.1 Global Efavirenz Annual Sales by Company (2018-2023)
3.1.2 Global Efavirenz Sales Market Share by Company (2018-2023)
3.2 Global Efavirenz Annual Revenue by Company (2018-2023)
3.2.1 Global Efavirenz Revenue by Company (2018-2023)
3.2.2 Global Efavirenz Revenue Market Share by Company (2018-2023)
3.3 Global Efavirenz Sale Price by Company
3.4 Key Manufacturers Efavirenz Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Efavirenz Product Location Distribution
3.4.2 Players Efavirenz Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EFAVIRENZ BY GEOGRAPHIC REGION
4.1 World Historic Efavirenz Market Size by Geographic Region (2018-2023)
4.1.1 Global Efavirenz Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Efavirenz Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Efavirenz Market Size by Country/Region (2018-2023)
4.2.1 Global Efavirenz Annual Sales by Country/Region (2018-2023)
4.2.2 Global Efavirenz Annual Revenue by Country/Region (2018-2023)
4.3 Americas Efavirenz Sales Growth
4.4 APAC Efavirenz Sales Growth
4.5 Europe Efavirenz Sales Growth
4.6 Middle East & Africa Efavirenz Sales Growth
5 AMERICAS
5.1 Americas Efavirenz Sales by Country
5.1.1 Americas Efavirenz Sales by Country (2018-2023)
5.1.2 Americas Efavirenz Revenue by Country (2018-2023)
5.2 Americas Efavirenz Sales by Type
5.3 Americas Efavirenz Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Efavirenz Sales by Region
6.1.1 APAC Efavirenz Sales by Region (2018-2023)
6.1.2 APAC Efavirenz Revenue by Region (2018-2023)
6.2 APAC Efavirenz Sales by Type
6.3 APAC Efavirenz Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Efavirenz by Country
7.1.1 Europe Efavirenz Sales by Country (2018-2023)
7.1.2 Europe Efavirenz Revenue by Country (2018-2023)
7.2 Europe Efavirenz Sales by Type
7.3 Europe Efavirenz Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Efavirenz by Country
8.1.1 Middle East & Africa Efavirenz Sales by Country (2018-2023)
8.1.2 Middle East & Africa Efavirenz Revenue by Country (2018-2023)
8.2 Middle East & Africa Efavirenz Sales by Type
8.3 Middle East & Africa Efavirenz Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efavirenz
10.3 Manufacturing Process Analysis of Efavirenz
10.4 Industry Chain Structure of Efavirenz
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Efavirenz Distributors
11.3 Efavirenz Customer
12 WORLD FORECAST REVIEW FOR EFAVIRENZ BY GEOGRAPHIC REGION
12.1 Global Efavirenz Market Size Forecast by Region
12.1.1 Global Efavirenz Forecast by Region (2024-2029)
12.1.2 Global Efavirenz Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Efavirenz Forecast by Type
12.7 Global Efavirenz Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Efavirenz Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Efavirenz Product Portfolios and Specifications
13.2.3 Teva Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Efavirenz Product Portfolios and Specifications
13.3.3 Mylan Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
13.4.1 Aurobindo Pharma Company Information
13.4.2 Aurobindo Pharma Efavirenz Product Portfolios and Specifications
13.4.3 Aurobindo Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aurobindo Pharma Main Business Overview
13.4.5 Aurobindo Pharma Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Efavirenz Product Portfolios and Specifications
13.5.3 Cipla Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Macleods Pharmaceuticals
13.6.1 Macleods Pharmaceuticals Company Information
13.6.2 Macleods Pharmaceuticals Efavirenz Product Portfolios and Specifications
13.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Macleods Pharmaceuticals Main Business Overview
13.6.5 Macleods Pharmaceuticals Latest Developments
13.7 Hetero
13.7.1 Hetero Company Information
13.7.2 Hetero Efavirenz Product Portfolios and Specifications
13.7.3 Hetero Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Main Business Overview
13.7.5 Hetero Latest Developments
13.8 Strides Pharma
13.8.1 Strides Pharma Company Information
13.8.2 Strides Pharma Efavirenz Product Portfolios and Specifications
13.8.3 Strides Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Strides Pharma Main Business Overview
13.8.5 Strides Pharma Latest Developments
13.9 Gilead Sciences
13.9.1 Gilead Sciences Company Information
13.9.2 Gilead Sciences Efavirenz Product Portfolios and Specifications
13.9.3 Gilead Sciences Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Gilead Sciences Main Business Overview
13.9.5 Gilead Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Efavirenz Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Efavirenz by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Efavirenz by Country/Region, 2018, 2022 & 2029
2.2 Efavirenz Segment by Type
2.2.1 Single Efavirenz
2.2.2 Two-drug combination
2.2.3 Three-drug combination
2.3 Efavirenz Sales by Type
2.3.1 Global Efavirenz Sales Market Share by Type (2018-2023)
2.3.2 Global Efavirenz Revenue and Market Share by Type (2018-2023)
2.3.3 Global Efavirenz Sale Price by Type (2018-2023)
2.4 Efavirenz Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Efavirenz Sales by Application
2.5.1 Global Efavirenz Sale Market Share by Application (2018-2023)
2.5.2 Global Efavirenz Revenue and Market Share by Application (2018-2023)
2.5.3 Global Efavirenz Sale Price by Application (2018-2023)
3 GLOBAL EFAVIRENZ BY COMPANY
3.1 Global Efavirenz Breakdown Data by Company
3.1.1 Global Efavirenz Annual Sales by Company (2018-2023)
3.1.2 Global Efavirenz Sales Market Share by Company (2018-2023)
3.2 Global Efavirenz Annual Revenue by Company (2018-2023)
3.2.1 Global Efavirenz Revenue by Company (2018-2023)
3.2.2 Global Efavirenz Revenue Market Share by Company (2018-2023)
3.3 Global Efavirenz Sale Price by Company
3.4 Key Manufacturers Efavirenz Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Efavirenz Product Location Distribution
3.4.2 Players Efavirenz Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EFAVIRENZ BY GEOGRAPHIC REGION
4.1 World Historic Efavirenz Market Size by Geographic Region (2018-2023)
4.1.1 Global Efavirenz Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Efavirenz Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Efavirenz Market Size by Country/Region (2018-2023)
4.2.1 Global Efavirenz Annual Sales by Country/Region (2018-2023)
4.2.2 Global Efavirenz Annual Revenue by Country/Region (2018-2023)
4.3 Americas Efavirenz Sales Growth
4.4 APAC Efavirenz Sales Growth
4.5 Europe Efavirenz Sales Growth
4.6 Middle East & Africa Efavirenz Sales Growth
5 AMERICAS
5.1 Americas Efavirenz Sales by Country
5.1.1 Americas Efavirenz Sales by Country (2018-2023)
5.1.2 Americas Efavirenz Revenue by Country (2018-2023)
5.2 Americas Efavirenz Sales by Type
5.3 Americas Efavirenz Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Efavirenz Sales by Region
6.1.1 APAC Efavirenz Sales by Region (2018-2023)
6.1.2 APAC Efavirenz Revenue by Region (2018-2023)
6.2 APAC Efavirenz Sales by Type
6.3 APAC Efavirenz Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Efavirenz by Country
7.1.1 Europe Efavirenz Sales by Country (2018-2023)
7.1.2 Europe Efavirenz Revenue by Country (2018-2023)
7.2 Europe Efavirenz Sales by Type
7.3 Europe Efavirenz Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Efavirenz by Country
8.1.1 Middle East & Africa Efavirenz Sales by Country (2018-2023)
8.1.2 Middle East & Africa Efavirenz Revenue by Country (2018-2023)
8.2 Middle East & Africa Efavirenz Sales by Type
8.3 Middle East & Africa Efavirenz Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efavirenz
10.3 Manufacturing Process Analysis of Efavirenz
10.4 Industry Chain Structure of Efavirenz
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Efavirenz Distributors
11.3 Efavirenz Customer
12 WORLD FORECAST REVIEW FOR EFAVIRENZ BY GEOGRAPHIC REGION
12.1 Global Efavirenz Market Size Forecast by Region
12.1.1 Global Efavirenz Forecast by Region (2024-2029)
12.1.2 Global Efavirenz Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Efavirenz Forecast by Type
12.7 Global Efavirenz Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Efavirenz Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Efavirenz Product Portfolios and Specifications
13.2.3 Teva Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Efavirenz Product Portfolios and Specifications
13.3.3 Mylan Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
13.4.1 Aurobindo Pharma Company Information
13.4.2 Aurobindo Pharma Efavirenz Product Portfolios and Specifications
13.4.3 Aurobindo Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aurobindo Pharma Main Business Overview
13.4.5 Aurobindo Pharma Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Efavirenz Product Portfolios and Specifications
13.5.3 Cipla Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Macleods Pharmaceuticals
13.6.1 Macleods Pharmaceuticals Company Information
13.6.2 Macleods Pharmaceuticals Efavirenz Product Portfolios and Specifications
13.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Macleods Pharmaceuticals Main Business Overview
13.6.5 Macleods Pharmaceuticals Latest Developments
13.7 Hetero
13.7.1 Hetero Company Information
13.7.2 Hetero Efavirenz Product Portfolios and Specifications
13.7.3 Hetero Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Main Business Overview
13.7.5 Hetero Latest Developments
13.8 Strides Pharma
13.8.1 Strides Pharma Company Information
13.8.2 Strides Pharma Efavirenz Product Portfolios and Specifications
13.8.3 Strides Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Strides Pharma Main Business Overview
13.8.5 Strides Pharma Latest Developments
13.9 Gilead Sciences
13.9.1 Gilead Sciences Company Information
13.9.2 Gilead Sciences Efavirenz Product Portfolios and Specifications
13.9.3 Gilead Sciences Efavirenz Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Gilead Sciences Main Business Overview
13.9.5 Gilead Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Efavirenz Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Efavirenz Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Efavirenz
Table 4. Major Players of Two-drug combination
Table 5. Major Players of Three-drug combination
Table 6. Global Efavirenz Sales by Type (2018-2023) & (K Units)
Table 7. Global Efavirenz Sales Market Share by Type (2018-2023)
Table 8. Global Efavirenz Revenue by Type (2018-2023) & ($ million)
Table 9. Global Efavirenz Revenue Market Share by Type (2018-2023)
Table 10. Global Efavirenz Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Efavirenz Sales by Application (2018-2023) & (K Units)
Table 12. Global Efavirenz Sales Market Share by Application (2018-2023)
Table 13. Global Efavirenz Revenue by Application (2018-2023)
Table 14. Global Efavirenz Revenue Market Share by Application (2018-2023)
Table 15. Global Efavirenz Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Efavirenz Sales by Company (2018-2023) & (K Units)
Table 17. Global Efavirenz Sales Market Share by Company (2018-2023)
Table 18. Global Efavirenz Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Efavirenz Revenue Market Share by Company (2018-2023)
Table 20. Global Efavirenz Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Efavirenz Producing Area Distribution and Sales Area
Table 22. Players Efavirenz Products Offered
Table 23. Efavirenz Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Efavirenz Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Efavirenz Sales Market Share Geographic Region (2018-2023)
Table 28. Global Efavirenz Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Efavirenz Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Efavirenz Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Efavirenz Sales Market Share by Country/Region (2018-2023)
Table 32. Global Efavirenz Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Efavirenz Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Efavirenz Sales by Country (2018-2023) & (K Units)
Table 35. Americas Efavirenz Sales Market Share by Country (2018-2023)
Table 36. Americas Efavirenz Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Efavirenz Revenue Market Share by Country (2018-2023)
Table 38. Americas Efavirenz Sales by Type (2018-2023) & (K Units)
Table 39. Americas Efavirenz Sales by Application (2018-2023) & (K Units)
Table 40. APAC Efavirenz Sales by Region (2018-2023) & (K Units)
Table 41. APAC Efavirenz Sales Market Share by Region (2018-2023)
Table 42. APAC Efavirenz Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Efavirenz Revenue Market Share by Region (2018-2023)
Table 44. APAC Efavirenz Sales by Type (2018-2023) & (K Units)
Table 45. APAC Efavirenz Sales by Application (2018-2023) & (K Units)
Table 46. Europe Efavirenz Sales by Country (2018-2023) & (K Units)
Table 47. Europe Efavirenz Sales Market Share by Country (2018-2023)
Table 48. Europe Efavirenz Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Efavirenz Revenue Market Share by Country (2018-2023)
Table 50. Europe Efavirenz Sales by Type (2018-2023) & (K Units)
Table 51. Europe Efavirenz Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Efavirenz Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Efavirenz Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Efavirenz Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Efavirenz Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Efavirenz Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Efavirenz Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Efavirenz
Table 59. Key Market Challenges & Risks of Efavirenz
Table 60. Key Industry Trends of Efavirenz
Table 61. Efavirenz Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Efavirenz Distributors List
Table 64. Efavirenz Customer List
Table 65. Global Efavirenz Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Efavirenz Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Efavirenz Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Efavirenz Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Efavirenz Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Efavirenz Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Efavirenz Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Efavirenz Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Efavirenz Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Efavirenz Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Efavirenz Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Efavirenz Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Efavirenz Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Efavirenz Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Bristol-Myers Squibb Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 80. Bristol-Myers Squibb Efavirenz Product Portfolios and Specifications
Table 81. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Bristol-Myers Squibb Main Business
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Teva Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva Efavirenz Product Portfolios and Specifications
Table 86. Teva Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. Mylan Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Efavirenz Product Portfolios and Specifications
Table 91. Mylan Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Aurobindo Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 95. Aurobindo Pharma Efavirenz Product Portfolios and Specifications
Table 96. Aurobindo Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Aurobindo Pharma Main Business
Table 98. Aurobindo Pharma Latest Developments
Table 99. Cipla Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 100. Cipla Efavirenz Product Portfolios and Specifications
Table 101. Cipla Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Cipla Main Business
Table 103. Cipla Latest Developments
Table 104. Macleods Pharmaceuticals Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 105. Macleods Pharmaceuticals Efavirenz Product Portfolios and Specifications
Table 106. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Macleods Pharmaceuticals Main Business
Table 108. Macleods Pharmaceuticals Latest Developments
Table 109. Hetero Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 110. Hetero Efavirenz Product Portfolios and Specifications
Table 111. Hetero Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Hetero Main Business
Table 113. Hetero Latest Developments
Table 114. Strides Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 115. Strides Pharma Efavirenz Product Portfolios and Specifications
Table 116. Strides Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Strides Pharma Main Business
Table 118. Strides Pharma Latest Developments
Table 119. Gilead Sciences Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 120. Gilead Sciences Efavirenz Product Portfolios and Specifications
Table 121. Gilead Sciences Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Gilead Sciences Main Business
Table 123. Gilead Sciences Latest Developments
Table 1. Efavirenz Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Efavirenz Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Efavirenz
Table 4. Major Players of Two-drug combination
Table 5. Major Players of Three-drug combination
Table 6. Global Efavirenz Sales by Type (2018-2023) & (K Units)
Table 7. Global Efavirenz Sales Market Share by Type (2018-2023)
Table 8. Global Efavirenz Revenue by Type (2018-2023) & ($ million)
Table 9. Global Efavirenz Revenue Market Share by Type (2018-2023)
Table 10. Global Efavirenz Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Efavirenz Sales by Application (2018-2023) & (K Units)
Table 12. Global Efavirenz Sales Market Share by Application (2018-2023)
Table 13. Global Efavirenz Revenue by Application (2018-2023)
Table 14. Global Efavirenz Revenue Market Share by Application (2018-2023)
Table 15. Global Efavirenz Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Efavirenz Sales by Company (2018-2023) & (K Units)
Table 17. Global Efavirenz Sales Market Share by Company (2018-2023)
Table 18. Global Efavirenz Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Efavirenz Revenue Market Share by Company (2018-2023)
Table 20. Global Efavirenz Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Efavirenz Producing Area Distribution and Sales Area
Table 22. Players Efavirenz Products Offered
Table 23. Efavirenz Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Efavirenz Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Efavirenz Sales Market Share Geographic Region (2018-2023)
Table 28. Global Efavirenz Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Efavirenz Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Efavirenz Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Efavirenz Sales Market Share by Country/Region (2018-2023)
Table 32. Global Efavirenz Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Efavirenz Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Efavirenz Sales by Country (2018-2023) & (K Units)
Table 35. Americas Efavirenz Sales Market Share by Country (2018-2023)
Table 36. Americas Efavirenz Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Efavirenz Revenue Market Share by Country (2018-2023)
Table 38. Americas Efavirenz Sales by Type (2018-2023) & (K Units)
Table 39. Americas Efavirenz Sales by Application (2018-2023) & (K Units)
Table 40. APAC Efavirenz Sales by Region (2018-2023) & (K Units)
Table 41. APAC Efavirenz Sales Market Share by Region (2018-2023)
Table 42. APAC Efavirenz Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Efavirenz Revenue Market Share by Region (2018-2023)
Table 44. APAC Efavirenz Sales by Type (2018-2023) & (K Units)
Table 45. APAC Efavirenz Sales by Application (2018-2023) & (K Units)
Table 46. Europe Efavirenz Sales by Country (2018-2023) & (K Units)
Table 47. Europe Efavirenz Sales Market Share by Country (2018-2023)
Table 48. Europe Efavirenz Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Efavirenz Revenue Market Share by Country (2018-2023)
Table 50. Europe Efavirenz Sales by Type (2018-2023) & (K Units)
Table 51. Europe Efavirenz Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Efavirenz Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Efavirenz Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Efavirenz Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Efavirenz Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Efavirenz Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Efavirenz Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Efavirenz
Table 59. Key Market Challenges & Risks of Efavirenz
Table 60. Key Industry Trends of Efavirenz
Table 61. Efavirenz Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Efavirenz Distributors List
Table 64. Efavirenz Customer List
Table 65. Global Efavirenz Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Efavirenz Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Efavirenz Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Efavirenz Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Efavirenz Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Efavirenz Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Efavirenz Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Efavirenz Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Efavirenz Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Efavirenz Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Efavirenz Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Efavirenz Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Efavirenz Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Efavirenz Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Bristol-Myers Squibb Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 80. Bristol-Myers Squibb Efavirenz Product Portfolios and Specifications
Table 81. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Bristol-Myers Squibb Main Business
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Teva Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 85. Teva Efavirenz Product Portfolios and Specifications
Table 86. Teva Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Teva Main Business
Table 88. Teva Latest Developments
Table 89. Mylan Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Efavirenz Product Portfolios and Specifications
Table 91. Mylan Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Aurobindo Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 95. Aurobindo Pharma Efavirenz Product Portfolios and Specifications
Table 96. Aurobindo Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Aurobindo Pharma Main Business
Table 98. Aurobindo Pharma Latest Developments
Table 99. Cipla Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 100. Cipla Efavirenz Product Portfolios and Specifications
Table 101. Cipla Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Cipla Main Business
Table 103. Cipla Latest Developments
Table 104. Macleods Pharmaceuticals Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 105. Macleods Pharmaceuticals Efavirenz Product Portfolios and Specifications
Table 106. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Macleods Pharmaceuticals Main Business
Table 108. Macleods Pharmaceuticals Latest Developments
Table 109. Hetero Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 110. Hetero Efavirenz Product Portfolios and Specifications
Table 111. Hetero Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Hetero Main Business
Table 113. Hetero Latest Developments
Table 114. Strides Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 115. Strides Pharma Efavirenz Product Portfolios and Specifications
Table 116. Strides Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Strides Pharma Main Business
Table 118. Strides Pharma Latest Developments
Table 119. Gilead Sciences Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 120. Gilead Sciences Efavirenz Product Portfolios and Specifications
Table 121. Gilead Sciences Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Gilead Sciences Main Business
Table 123. Gilead Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Efavirenz
Figure 2. Efavirenz Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efavirenz Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Efavirenz Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Efavirenz Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Efavirenz
Figure 10. Product Picture of Two-drug combination
Figure 11. Product Picture of Three-drug combination
Figure 12. Global Efavirenz Sales Market Share by Type in 2022
Figure 13. Global Efavirenz Revenue Market Share by Type (2018-2023)
Figure 14. Efavirenz Consumed in Adults
Figure 15. Global Efavirenz Market: Adults (2018-2023) & (K Units)
Figure 16. Efavirenz Consumed in Children
Figure 17. Global Efavirenz Market: Children (2018-2023) & (K Units)
Figure 18. Global Efavirenz Sales Market Share by Application (2022)
Figure 19. Global Efavirenz Revenue Market Share by Application in 2022
Figure 20. Efavirenz Sales Market by Company in 2022 (K Units)
Figure 21. Global Efavirenz Sales Market Share by Company in 2022
Figure 22. Efavirenz Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Efavirenz Revenue Market Share by Company in 2022
Figure 24. Global Efavirenz Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Efavirenz Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Efavirenz Sales 2018-2023 (K Units)
Figure 27. Americas Efavirenz Revenue 2018-2023 ($ Millions)
Figure 28. APAC Efavirenz Sales 2018-2023 (K Units)
Figure 29. APAC Efavirenz Revenue 2018-2023 ($ Millions)
Figure 30. Europe Efavirenz Sales 2018-2023 (K Units)
Figure 31. Europe Efavirenz Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Efavirenz Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Efavirenz Revenue 2018-2023 ($ Millions)
Figure 34. Americas Efavirenz Sales Market Share by Country in 2022
Figure 35. Americas Efavirenz Revenue Market Share by Country in 2022
Figure 36. Americas Efavirenz Sales Market Share by Type (2018-2023)
Figure 37. Americas Efavirenz Sales Market Share by Application (2018-2023)
Figure 38. United States Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Efavirenz Sales Market Share by Region in 2022
Figure 43. APAC Efavirenz Revenue Market Share by Regions in 2022
Figure 44. APAC Efavirenz Sales Market Share by Type (2018-2023)
Figure 45. APAC Efavirenz Sales Market Share by Application (2018-2023)
Figure 46. China Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Efavirenz Sales Market Share by Country in 2022
Figure 54. Europe Efavirenz Revenue Market Share by Country in 2022
Figure 55. Europe Efavirenz Sales Market Share by Type (2018-2023)
Figure 56. Europe Efavirenz Sales Market Share by Application (2018-2023)
Figure 57. Germany Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Efavirenz Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Efavirenz Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Efavirenz Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Efavirenz Sales Market Share by Application (2018-2023)
Figure 66. Egypt Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Efavirenz in 2022
Figure 72. Manufacturing Process Analysis of Efavirenz
Figure 73. Industry Chain Structure of Efavirenz
Figure 74. Channels of Distribution
Figure 75. Global Efavirenz Sales Market Forecast by Region (2024-2029)
Figure 76. Global Efavirenz Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Efavirenz Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Efavirenz Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Efavirenz Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Efavirenz Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Efavirenz
Figure 2. Efavirenz Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efavirenz Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Efavirenz Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Efavirenz Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Efavirenz
Figure 10. Product Picture of Two-drug combination
Figure 11. Product Picture of Three-drug combination
Figure 12. Global Efavirenz Sales Market Share by Type in 2022
Figure 13. Global Efavirenz Revenue Market Share by Type (2018-2023)
Figure 14. Efavirenz Consumed in Adults
Figure 15. Global Efavirenz Market: Adults (2018-2023) & (K Units)
Figure 16. Efavirenz Consumed in Children
Figure 17. Global Efavirenz Market: Children (2018-2023) & (K Units)
Figure 18. Global Efavirenz Sales Market Share by Application (2022)
Figure 19. Global Efavirenz Revenue Market Share by Application in 2022
Figure 20. Efavirenz Sales Market by Company in 2022 (K Units)
Figure 21. Global Efavirenz Sales Market Share by Company in 2022
Figure 22. Efavirenz Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Efavirenz Revenue Market Share by Company in 2022
Figure 24. Global Efavirenz Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Efavirenz Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Efavirenz Sales 2018-2023 (K Units)
Figure 27. Americas Efavirenz Revenue 2018-2023 ($ Millions)
Figure 28. APAC Efavirenz Sales 2018-2023 (K Units)
Figure 29. APAC Efavirenz Revenue 2018-2023 ($ Millions)
Figure 30. Europe Efavirenz Sales 2018-2023 (K Units)
Figure 31. Europe Efavirenz Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Efavirenz Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Efavirenz Revenue 2018-2023 ($ Millions)
Figure 34. Americas Efavirenz Sales Market Share by Country in 2022
Figure 35. Americas Efavirenz Revenue Market Share by Country in 2022
Figure 36. Americas Efavirenz Sales Market Share by Type (2018-2023)
Figure 37. Americas Efavirenz Sales Market Share by Application (2018-2023)
Figure 38. United States Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Efavirenz Sales Market Share by Region in 2022
Figure 43. APAC Efavirenz Revenue Market Share by Regions in 2022
Figure 44. APAC Efavirenz Sales Market Share by Type (2018-2023)
Figure 45. APAC Efavirenz Sales Market Share by Application (2018-2023)
Figure 46. China Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Efavirenz Sales Market Share by Country in 2022
Figure 54. Europe Efavirenz Revenue Market Share by Country in 2022
Figure 55. Europe Efavirenz Sales Market Share by Type (2018-2023)
Figure 56. Europe Efavirenz Sales Market Share by Application (2018-2023)
Figure 57. Germany Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Efavirenz Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Efavirenz Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Efavirenz Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Efavirenz Sales Market Share by Application (2018-2023)
Figure 66. Egypt Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Efavirenz Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Efavirenz in 2022
Figure 72. Manufacturing Process Analysis of Efavirenz
Figure 73. Industry Chain Structure of Efavirenz
Figure 74. Channels of Distribution
Figure 75. Global Efavirenz Sales Market Forecast by Region (2024-2029)
Figure 76. Global Efavirenz Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Efavirenz Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Efavirenz Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Efavirenz Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Efavirenz Revenue Market Share Forecast by Application (2024-2029)
